Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Headache and Neurological Pain

Headache and Neurological Pain

Our research group is focused on studying the pathophysiology of migraine and other primary headaches using preclinical, translational and clinical research.

Migraine will allow us to define the brain’s adaptive, sensory/cognitive functions, through genetics, epigenetics, neurophysiology, neuromolecular and neuroanatomical information with an interest in developing clinical therapeutic solutions, with the goal on having an impact on suffering and increasing the well-being.

Team

Patricia Pozo Rosich

Patricia Pozo Rosich

Head of group
Headache and Neurological Pain
Read more
Marta Torres Ferrús

Marta Torres Ferrús

Headache and Neurological Pain
Read more
Marta Vila Pueyo

Marta Vila Pueyo

Postdoctoral researcher
Headache and Neurological Pain
Read more
Alicia Alpuente Ruiz

Alicia Alpuente Ruiz

Predoctoral researcher
Headache and Neurological Pain
Read more
Adria Vila Ballo

Adria Vila Ballo

Postdoctoral researcher
Headache and Neurological Pain
Read more
Angela Barbara Marti Marca

Angela Barbara Marti Marca

Predoctoral researcher
Headache and Neurological Pain
Read more
Patricia Pozo Rosich

Patricia Pozo Rosich

Head of group
Headache and Neurological Pain
Read more
Marta Torres Ferrús

Marta Torres Ferrús

Headache and Neurological Pain
Read more
Marta Vila Pueyo

Marta Vila Pueyo

Postdoctoral researcher
Headache and Neurological Pain
Read more
Alicia Alpuente Ruiz

Alicia Alpuente Ruiz

Predoctoral researcher
Headache and Neurological Pain
Read more
Adria Vila Ballo

Adria Vila Ballo

Postdoctoral researcher
Headache and Neurological Pain
Read more
Angela Barbara Marti Marca

Angela Barbara Marti Marca

Predoctoral researcher
Headache and Neurological Pain
Read more

Research lines

Genetics of migraine and other primary headaches

IP: -

Neuroimaging research of migraine and other primary headaches

IP: -

Neurophysiological research of migraine and other primary headaches

IP: -

Projects

Differential expression of microRNAs in migraine patients

IP: Patricia Pozo Rosich
Collaborators: Marta Vila Pueyo
Funding agency: Instituto de Salud Carlos III
Funding: 80598
Reference: CD20/00019
Duration: 01/01/2021 - 28/06/2024

SENSOMIG IMPACT OF SENSORY AND STRESSFUL STIMULI IN A PRECLINICAL MODEL OF CHRONIC MIGRAINE

IP: Patricia Pozo Rosich
Collaborators: Marta Vila Pueyo
Funding agency: EUROPEAN COMMISSION
Funding: 172932.48
Reference: SENSOMIG_H2020-MSCA-IF2020
Duration: 01/09/2022 - 31/08/2024

Biomarcadores neurofisiológicos en migraña

IP: Patricia Pozo Rosich
Collaborators: Angela Barbara Marti Marca
Funding agency: Fundació Institut de Recerca HUVH
Funding: 50649.27
Reference: VHIR/BEQUESPREDOC/2020/MARTI
Duration: 01/04/2021 - 30/03/2024

IJC

IP: Patricia Pozo Rosich
Collaborators: Adria Vila Ballo, Judit Álvarez González
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 97800
Reference: IJC2020-043139-I
Duration: 01/07/2022 - 30/06/2025

Ministerio de Ciencia

Sol·licitud Juan de la Cierva-Formación

IP: Patricia Pozo Rosich
Collaborators: Adria Vila Ballo
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 50000
Reference: FJC2018-036804-I
Duration: 01/04/2020 - 31/03/2022

Cefaleas y síndromes post-traumatismo craneoencefálico

IP: Patricia Pozo Rosich
Collaborators: Edoardo Caronna
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM20/00217
Duration: 01/01/2021 - 31/12/2022

Differential expression of microRNAs in migraine patients

IP: Patricia Pozo Rosich
Collaborators: Marta Vila Pueyo
Funding agency: Instituto de Salud Carlos III
Funding: 80598
Reference: CD20/00019
Duration: 01/01/2021 - 28/06/2024

SENSOMIG IMPACT OF SENSORY AND STRESSFUL STIMULI IN A PRECLINICAL MODEL OF CHRONIC MIGRAINE

IP: Patricia Pozo Rosich
Collaborators: Marta Vila Pueyo
Funding agency: EUROPEAN COMMISSION
Funding: 172932.48
Reference: SENSOMIG_H2020-MSCA-IF2020
Duration: 01/09/2022 - 31/08/2024

Sol·licitud Juan de la Cierva-Formación

IP: Patricia Pozo Rosich
Collaborators: Adria Vila Ballo
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 50000
Reference: FJC2018-036804-I
Duration: 01/04/2020 - 31/03/2022

Cefaleas y síndromes post-traumatismo craneoencefálico

IP: Patricia Pozo Rosich
Collaborators: Edoardo Caronna
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM20/00217
Duration: 01/01/2021 - 31/12/2022

Differential expression of microRNAs in migraine patients

IP: Patricia Pozo Rosich
Collaborators: Marta Vila Pueyo
Funding agency: Instituto de Salud Carlos III
Funding: 80598
Reference: CD20/00019
Duration: 01/01/2021 - 28/06/2024

Biomarcadores neurofisiológicos en migraña

IP: Patricia Pozo Rosich
Collaborators: Angela Barbara Marti Marca
Funding agency: Fundació Institut de Recerca HUVH
Funding: 50649.27
Reference: VHIR/BEQUESPREDOC/2020/MARTI
Duration: 01/04/2021 - 30/03/2024

Sol·licitud Juan de la Cierva-Formación

IP: Patricia Pozo Rosich
Collaborators: Adria Vila Ballo
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 50000
Reference: FJC2018-036804-I
Duration: 01/04/2020 - 31/03/2022

SAMBA: Análisis de biomarcadores de migraña en saliva

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 70785
Reference: PI16/01525
Duration: 01/01/2017 - 31/12/2020

Títol: Cluster Emergent del Cervell Humà (CECH)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Generalitat de Catalunya
Funding: 131250
Reference: 001-P-001682
Duration: 01/01/2019 - 31/12/2022

AhEAD: Algoritmo de predicción de Eficacia de respuesta A tratamiento preventivo en pacientes con migraña crónica: marcaDores biológicos y clínicos

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Juli Alonso Farre, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Edoardo Caronna
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/01684
Duration: 01/01/2020 - 31/12/2022

Estudio de la adaptación del cerebro a los estímulos: Migraine Adaptive Brain Program

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 82476.49
Reference: SLT006/17/00265
Duration: 21/05/2018 - 31/12/2019

SAMBA: Análisis de biomarcadores de migraña en saliva

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 70785
Reference: PI16/01525
Duration: 01/01/2017 - 31/12/2020

Títol: Cluster Emergent del Cervell Humà (CECH)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Generalitat de Catalunya
Funding: 131250
Reference: 001-P-001682
Duration: 01/01/2019 - 31/12/2022

A multidisciplinary approach to the identification of BIOmarkers of MIGraine: a proof of concept study based on the stratification of responders CGRP monoclonal Antibodies

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: CLIENT
Reference: EC-ISCIII/ERANET-NEURON/POZO
Duration: 10/10/2019 - 10/10/2019

Estudio de la adaptación del cerebro a los estímulos: Migraine Adaptive Brain Program

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 82476.49
Reference: SLT006/17/00265
Duration: 21/05/2018 - 31/12/2019

Estudi de la migranya mitjançant neuroimatge funcional

IP: Marta Torres Ferrús
Collaborators: Patricia Pozo Rosich, Joan Castell Conesa, Gemma Cuberas Borros, Carles Lorenzo Bosquet, Manuel Quintana Luque
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 10000
Reference: MUTUAL.MEDICA/2015/TORRES
Duration: 01/03/2016 - 01/03/2018

SAMBA: Análisis de biomarcadores de migraña en saliva

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 70785
Reference: PI16/01525
Duration: 01/01/2017 - 31/12/2020

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 45000
Reference: PM-CAIXA-2014-01
Duration: 07/01/2015 - 06/01/2017

microMIG: searching for new biomarkers in migraine by microRNA expression profile analysis

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: MIGRAINE RESEARCH FOUNDATION
Funding: 45117.97
Reference: MICROMIG_MIGRAINE2015
Duration: 21/01/2016 - 31/12/2017

Estudi de la migranya mitjançant neuroimatge funcional

IP: Marta Torres Ferrús
Collaborators: Patricia Pozo Rosich, Joan Castell Conesa, Gemma Cuberas Borros, Carles Lorenzo Bosquet, Manuel Quintana Luque
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 10000
Reference: MUTUAL.MEDICA/2015/TORRES
Duration: 01/03/2016 - 01/03/2018

SAMBA: Análisis de biomarcadores de migraña en saliva

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 70785
Reference: PI16/01525
Duration: 01/01/2017 - 31/12/2020

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 45000
Reference: PM-CAIXA-2014-01
Duration: 07/01/2015 - 06/01/2017

microMIG: searching for new biomarkers in migraine by microRNA expression profile analysis

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: MIGRAINE RESEARCH FOUNDATION
Funding: 45117.97
Reference: MICROMIG_MIGRAINE2015
Duration: 21/01/2016 - 31/12/2017

Estudio Funcional de la migraña mediante PET-FDG

IP: Marta Torres Ferrús
Collaborators: -
Funding agency: Sociedad Española de Neurologia
Funding: 6000
Reference: SEN/GECSEN/2015/TORRES
Duration: 01/01/2016 - 01/07/2016

Estudi de la migranya mitjançant neuroimatge funcional

IP: Marta Torres Ferrús
Collaborators: Patricia Pozo Rosich, Joan Castell Conesa, Gemma Cuberas Borros, Carles Lorenzo Bosquet, Manuel Quintana Luque
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 10000
Reference: MUTUAL.MEDICA/2015/TORRES
Duration: 01/03/2016 - 01/03/2018

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 45000
Reference: PM-CAIXA-2014-01
Duration: 07/01/2015 - 06/01/2017

FUNAMIG: análisis funcional del estudio CHROMIG (genotipado del riesgo de desarrollar migraña crónica)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI10/00876
Duration: 01/01/2011 - 30/06/2015

FUNAMIG: análisis funcional del estudio CHROMIG (genotipado del riesgo de desarrollar migraña crónica)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI10/00876
Duration: 01/01/2011 - 30/06/2015

FUNAMIG: análisis funcional del estudio CHROMIG (genotipado del riesgo de desarrollar migraña crónica)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI10/00876
Duration: 01/01/2011 - 30/06/2015

CHROMIG: genotipatge del risc de desenvolupar migranya crònica

IP: Patricia Pozo Rosich
Collaborators: Feliu Titus Albareda, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 199413.75
Reference: MARATV3_072310
Duration: 16/01/2008 - 31/03/2012

FUNAMIG: análisis funcional del estudio CHROMIG (genotipado del riesgo de desarrollar migraña crónica)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI10/00876
Duration: 01/01/2011 - 30/06/2015

Data-mining for migraine endophenotypes using genome-wide analysis data

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: AGAUR
Funding: 12872
Reference: 2010 BE1 00744
Duration: 01/04/2011 - 28/10/2011

CHROMIG: genotipatge del risc de desenvolupar migranya crònica

IP: Patricia Pozo Rosich
Collaborators: Feliu Titus Albareda, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 199413.75
Reference: MARATV3_072310
Duration: 16/01/2008 - 31/03/2012

FUNAMIG: análisis funcional del estudio CHROMIG (genotipado del riesgo de desarrollar migraña crónica)

IP: Patricia Pozo Rosich
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI10/00876
Duration: 01/01/2011 - 30/06/2015

CHROMIG: genotipatge del risc de desenvolupar migranya crònica

IP: Patricia Pozo Rosich
Collaborators: Feliu Titus Albareda, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 199413.75
Reference: MARATV3_072310
Duration: 16/01/2008 - 31/03/2012

CHROMIG: genotipatge del risc de desenvolupar migranya crònica

IP: Patricia Pozo Rosich
Collaborators: Feliu Titus Albareda, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 199413.75
Reference: MARATV3_072310
Duration: 16/01/2008 - 31/03/2012

CHROMIG: genotipatge del risc de desenvolupar migranya crònica

IP: Patricia Pozo Rosich
Collaborators: Feliu Titus Albareda, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 199413.75
Reference: MARATV3_072310
Duration: 16/01/2008 - 31/03/2012

Publications

Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.

PMID: 35166156
Journal: CEPHALALGIA
Year: 2022
Reference: Cephalalgia. 2022 Jul;42(8):804-809. doi: 10.1177/03331024211068074. Epub 2022 Feb 15.
Impact factor: 6.295
Publication type: Paper in international publication
Authors: Pozo-Rosich, Patricia; de Lorenzo, Inigo; Garcia-Azorin, David; Layos-Romero, Almudena; Porta-Etessam, Jesus; Membrilla, Javier A; Caronna, Edoardo; Gonzalez-Martinez, Alicia; Mencia, Alvaro Sierra; Segura, Tomas et al.
DOI: 10.1177/03331024211068074

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Journal: LANCET NEUROLOGY
Year: 2022
Reference: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Impact factor: 44.182
Publication type: Paper in international publication
Authors: Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjorn; Ashina, Messoud et al.
DOI: 10.1016/S1474-4422(22)00185-5

Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.

PMID: 35791285
Journal: CEPHALALGIA
Year: 2022
Reference: Cephalalgia. 2022 Jul 5:3331024221110102. doi: 10.1177/03331024221110102.
Impact factor: 6.295
Publication type: Paper in international publication
Authors: Steiner, Timothy J; Terwindt, Gisela M; Katsarava, Zaza; Pozo-Rosich, Patricia; Gantenbein, Andreas R; Roche, Sarah L; Dell'Agnello, Grazia; Tassorelli, Cristina et al.
DOI: 10.1177/03331024221110102

Avoidance behaviour modulates but does not condition phonophobia in migraine.

PMID: 35815637
Journal: CEPHALALGIA
Year: 2022
Reference: Cephalalgia. 2022 Jul 9:3331024221111772. doi: 10.1177/03331024221111772.
Impact factor: 6.295
Publication type: Paper in international publication
Authors: Pozo-Rosich, Patricia, Gallardo, Victor Jose, Caronna, Edoardo, Vila-Ballo, Adria, Marti-Marca, Angela, Cerda-Company, Xim, Ikumi, Nara et al.
DOI: 10.1177/03331024221111772

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study.

PMID: 34903177
Journal: JOURNAL OF HEADACHE AND PAIN
Year: 2021
Reference: J Headache Pain. 2021 Dec 13;22(1):151. doi: 10.1186/s10194-021-01366-9.
Impact factor: 7.277
Publication type: Paper in international publication
Authors: Gallardo, Victor J, Alpuente, Alicia, Pozo-Rosich, Patricia, Torres-Ferrus, Marta, Caronna, Edoardo et al.
DOI: 10.1186/s10194-021-01366-9

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research.

PMID: 34766205
Journal: Current Pain and Headache Reports
Year: 2021
Reference: Curr Pain Headache Rep. 2021 Nov 11;25(11):73. doi: 10.1007/s11916-021-00987-8.
Impact factor: 3.494
Publication type: Review in international publication
Authors: Caronna, Edoardo, Pozo-Rosich, Patricia et al.
DOI: 10.1007/s11916-021-00987-8

The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish.

PMID: 34601726
Journal: HEADACHE
Year: 2021
Reference: Headache. 2021 Oct;61(9):1403-1410. doi: 10.1111/head.14225. Epub 2021 Oct 3.
Impact factor: 5.887
Publication type: Paper in international publication
Authors: Gallardo, Victor J, Alpuente, Alicia, Cerda-Company, Xim, Torres-Ferrus, Marta, Sanchez Del Rio, Margarita, Lainez, Jose Miguel, Leira, Rogelio, Trochet, Jerome, Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.14225

Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.

PMID: 34564833
Journal: Pain and Therapy
Year: 2021
Reference: Pain Ther. 2021 Dec;10(2):1605-1618. doi: 10.1007/s40122-021-00328-y. Epub 2021 Sep 26.
Impact factor: 5.725
Publication type: Paper in international publication
Authors: Kamm, Katharina, Ruscheweyh, Ruth, Russo, Marco, Torelli, Paola, Filatova, Elena, Latysheva, Nina, Gryglas-Dworak, Anna, Straburzynski, Marcin, Butera, Calogera, Colombo, Bruno et al.
DOI: 10.1007/s40122-021-00328-y

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution.

PMID: 33146036
Journal: CEPHALALGIA
Year: 2020
Reference: Cephalalgia. 2020 Nov;40(13):1410-1421. doi: 10.1177/0333102420965157.
Impact factor: 4.868
Publication type: Paper in international publication
Authors: Caronna, Edoardo, Ballve, Alejandro, Llaurado, Arnau, Gallardo, Victor Jose, Maria Ariton, Diana, Lallana, Sofia, Maza, Samuel Lopez, Gadea, Marta Olive, Quibus, Laura, Restrepo, Juan Luis et al.
DOI: 10.1177/0333102420965157

Visual-reward driven changes of movement during action execution.

PMID: 32968102
Journal: Scientific Reports
Year: 2020
Reference: Sci Rep. 2020 Sep 23;10(1):15527. doi: 10.1038/s41598-020-72220-2.
Impact factor: 3.998
Publication type: Paper in international publication
Authors: Marti-Marca, Angela, Deco, Gustavo, Cos, Ignasi et al.
DOI: 10.1038/s41598-020-72220-2

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence.

PMID: 32664898
Journal: JOURNAL OF HEADACHE AND PAIN
Year: 2020
Reference: J Headache Pain. 2020 Jul 14;21(1):90. doi: 10.1186/s10194-020-01135-0.
Impact factor: 4.797
Publication type: Review in international publication
Authors: Caronna, Edoardo, Benemei, Silvia, Labastida-Ramirez, Alejandro, Abramova, Ekaterina, Brunelli, Nicoletta, Diana, Paola, Gapeshin, Roman, Hofacker, Maxi Dana, Pias, Enrique Martinez, Maestrini, Ilaria et al.
DOI: 10.1186/s10194-020-01135-0

Impact of Puberty in Pediatric Migraine: A Pilot Prospective Study.

PMID: 32657062
Journal: Journal of Clinical Neurology
Year: 2020
Reference: J Clin Neurol. 2020 Jul;16(3):416-422. doi: 10.3988/jcn.2020.16.3.416.
Impact factor: 2.439
Publication type: Paper in international publication
Authors: Fonseca, Elena, Macaya, Alfons, Pozo-Rosich, Patricia, Gallardo, Victor Jose, Torres-Ferrus, Marta et al.
DOI: 10.3988/jcn.2020.16.3.416

Working memory updating training modulates a cascade of event-related potentials depending on task load.

PMID: 31513849
Journal: NEUROBIOLOGY OF LEARNING AND MEMORY
Year: 2019
Reference: Neurobiol Learn Mem. 2019 Dec;166:107085. doi: 10.1016/j.nlm.2019.107085. Epub 2019 Sep 9.
Impact factor: 3.01
Publication type: Paper in international publication
Authors: Salmi, Juha, Vila-Ballo, Adria, Soveri, Anna, Rostan, Carles, Rodriguez-Fornells, Antoni, Lehtonen, Minna, Laine, Matti et al.
DOI: 10.1016/j.nlm.2019.107085

Early efficacy and late gain in chronic and high-frequency episodic migraine with OnabotulinumtoxinA.

PMID: 31220392
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2019
Reference: Eur J Neurol. 2019 Dec;26(12):1464-1470. doi: 10.1111/ene.14028. Epub 2019 Jul 18.
Impact factor: 4.387
Publication type: Paper in international publication
Authors: Alpuente, Alicia, Gallardo, Victor Jose, Torres-Ferrus, Marta, Alvarez-Sabin, Jose, Pozo-Rosich, Patricia et al.
DOI: 10.1111/ene.14028

How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective.

PMID: 30950844
Journal: CURRENT OPINION IN NEUROLOGY
Year: 2019
Reference: Curr Opin Neurol. 2019 Jun;32(3):395-404. doi: 10.1097/WCO.0000000000000689.
Impact factor: 4.647
Publication type: Paper in international publication
Authors: Torres-Ferrus, Marta, Alpuente, Alicia, Pozo-Rosich, Patricia et al.
DOI: 10.1097/WCO.0000000000000689

Perampanel: A therapeutic alternative in refractory status epilepticus associated with MELAS syndrome.

PMID: 30834194
Journal: Epilepsy & behavior case reports
Year: 2019
Reference: Epilepsy Behav Case Rep. 2019 Feb 7;11:92-95. doi: 10.1016/j.ebcr.2019.01.008. eCollection 2019.
Impact factor: 0
Publication type: Paper in international publication
Authors: Santamarina, Estevo, Alpuente, Alicia, Maisterra, Olga, Sueiras, Maria, Sarria, Silvana, Guzman, Lorena, Abraira, Laura, Salas-Puig, Javier, Toledo, Manuel et al.
DOI: 10.1016/j.ebcr.2019.01.008

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse.

PMID: 30386285
Journal: Frontiers in Neurology
Year: 2018
Reference: Front Neurol. 2018 Oct 16;9:808. doi: 10.3389/fneur.2018.00808. eCollection 2018.
Impact factor: 3.508
Publication type: Paper in international publication
Authors: Caronna, Edoardo, Gallardo, Victor Jose, Hernandez-Beltran, Natalia, Torres-Ferrus, Marta, Pozo-Rosich, Patricia et al.
DOI: 10.3389/fneur.2018.00808

Cost of status epilepticus (SE): Effects of delayed treatment and SE duration.

PMID: 30384104
Journal: EPILEPSY & BEHAVIOR
Year: 2018
Reference: Epilepsy Behav. 2018 Dec;89:8-14. doi: 10.1016/j.yebeh.2018.09.046. Epub 2018 Oct 26.
Impact factor: 2.6
Publication type: Paper in international publication
Authors: Santamarina, Estevo, Parejo, Beatriz, Abraira, Laura, Gutierrez-Viedma, Alvaro, Alpuente, Alicia, Abarrategui, Belen, Toledo, Manuel, Mazuela, Gonzalo, Salas-Puig, Xavier, Garcia-Morales, Irene et al.
DOI: 10.1016/j.yebeh.2018.09.046

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis.

PMID: 30143565
Journal: NEUROLOGY
Year: 2018
Reference: Neurology. 2018 Sep 25;91(13):622-624. doi: 10.1212/WNL.0000000000006251. Epub 2018 Aug 24.
Impact factor: 8.055
Publication type: Paper in international publication
Authors: Midaglia, Luciana, Gratacos, Margarida, Caronna, Edoardo, Raguer, Nuria, Sastre-Garriga, Jaume, Montalban, Xavier, Tintore, Mar et al.
DOI: 10.1212/WNL.0000000000006251

Neural signatures for active maintenance and interference during working memory updating.

PMID: 29339147
Journal: BIOLOGICAL PSYCHOLOGY
Year: 2018
Reference: Biol Psychol. 2018 Feb;132:233-243. doi: 10.1016/j.biopsycho.2018.01.007. Epub 2018 Jan 12.
Impact factor: 2.891
Publication type: Paper in international publication
Authors: Vila-Ballo, Adria, Salmi, Juha, Soveri, Anna, Lehtonen, Minna, Laine, Matti, Rodriguez-Fornells, Antoni et al.
DOI: 10.1016/j.biopsycho.2018.01.007

Blog

News

Premis BIC 2022

Vall d’Hebron, guardonat amb els Premis Best in Class de Gaceta Médica en atenció al pacient amb cefalees i esclerosi múlti

Aquests guardons reconeixen els millors serveis i unitats de l’Estat, tant públics com privats, que busquen l’excel•lència en l’atenció que presten als seus pacients.

dolor vall hebron jornada migranya

Vall d'Hebron estudia variants genètiques i fenotips per crear teràpies dirigides i personalitzades contra el dolor

La 4º jornada del maneig integral del dolor busca agilitzar la transferència d’estudis preclínics a l’assistència per millorar la qualitat de vida dels pacients

Coronavirus

Dos anys de recerca contra la Covid-19

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

Job offers

Biostatistician-Headache Clinical Unit.
Start date:
30/01/2023
End date:
13/02/2023
Document: Download
Neurologist-Headache Unit.
Start date:
19/12/2022
End date:
02/01/2023
Document: Download
Biostatistician-Headache Clinical Unit.
Start date:
05/12/2022
End date:
31/12/2022
Document: Download